We investigated the role of complement in the pathogenesis of the demyelinating polyneuropathy that occurs in some patients with IgM monoclonal gammopathy. Seven patients with chronic sensorimotor polyneuropathy and IgM monoclonal gammopathy were examined. In six patients, the monoclonal protein recognized an epitope shared by myelin-associated glycoprotein and two peripheral-nerve glycolipids, whereas in one patient, IgM bound to an unidentified myelin antigen. Direct and indirect immunofluorescence and immunoperoxidase assays showed colocalization along the myelin sheaths of peripheral-nerve fibers of monoclonal protein with complement components C1q, C3d, and C5. In addition, terminal-complement complex that was not associated with S protein was detected in myelin sheaths. It appeared that alterations in myelin geometry caused by the separation of myelin lamellae corresponded to sites at which terminal-complement complex was deposited. We conclude that demyelination in polyneuropathy associated with IgM monoclonal gammopathy may be mediated by complement.
Source Information
Istituto di Neurologia, Universita di Verona, Italy.
This article has been cited by other articles:
Levine, T, Pestronk, A, Florence, J, Al-Lozi, M T, Lopate, G, Miller, T, Ramneantu, I, Waheed, W, Stambuk, M, Stone, M J, Choksi, R
(2006). Peripheral neuropathies in Waldenstrom's macroglobulinaemia. J. Neurol. Neurosurg. Psychiatry
77: 224-228
[Abstract][Full Text]
de Jonge, R. R., van Schaik, I. N., Vreijling, J. P., Troost, D., Baas, F.
(2004). Expression of complement components in the peripheral nervous system. Hum Mol Genet
13: 295-302
[Abstract][Full Text]
Nakano, A., Mitsui, T., Endo, I., Takeda, Y., Ozaki, S., Matsumoto, T.
(2001). Solitary plasmacytoma with VEGF overproduction: Report of a patient with polyneuropathy. Neurology
56: 818-819
[Full Text]
MARIETTE, X., BROUET, J.-C., CHEVRET, S., LEGER, J.-M., CLAVELOU, P., POUGET, J., VALLAT, J.-M., VIAL, C.
(2000). A randomised double blind trial versus placebo does not confirm the benefit of alpha -interferon in polyneuropathy associated with monoclonal IgM. J. Neurol. Neurosurg. Psychiatry
69: 279-280
[Full Text]
Nobile-Orazio, E., Meucci, N., Baldini, L., Di Troia, A., Scarlato, G.
(2000). Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies. Brain
123: 710-717
[Abstract][Full Text]
Dimopoulos, M. A., Panayiotidis, P., Moulopoulos, L. A., Sfikakis, P., Dalakas, M.
(2000). Waldenstrom’s Macroglobulinemia: Clinical Features, Complications, and Management. JCO
18: 214-214
[Abstract][Full Text]
Mariette, X., Chastang, C., Louboutin, J.-P., Leger, J.-M., Clavelou, P., Brouet, J.-C.
(1997). A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. J. Neurol. Neurosurg. Psychiatry
63: 28-34
[Abstract][Full Text]
Previous
